Cholesterol‐lowering drugs, particularly statins, have broad clinical implications.[59, 60, 61] Our study shows the potential therapeutic implications of these drugs, as they exhibit anticancer properties by reducing PD‐L1 expression in cancer cells and modulating cholesterol metabolism in macrophages via the XBP1 transcription factor. This evidence concerns the gene XBP1 and cancer.